Chemokines are a class of low-molecular-weight proteins that induce chemotaxis and are implicated in the modulation of angiogenesis. The imbalance among angiogenic and antiangiogenic chemokines can promote the development of several conditions, including chronic inflammation, dysplastic transformation and cancer. In this review, we describe the activity and clinical significance of chemokines in prostate and renal tumors and provide an update on ongoing studies in this setting.
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets / Cimadamore, Alessia; Scarpelli, Marina; Piva, Francesco; Massari, Francesco; Gasparrini, Silvia; Doria, Andrea; Cheng, Liang; Lopez beltran, Antonio; Montironi, Rodolfo. - In: FUTURE ONCOLOGY. - ISSN 1479-6694. - STAMPA. - 13:12(2017), pp. 1105-1114. [10.2217/fon-2016-0481]
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets
CIMADAMORE, ALESSIA;SCARPELLI, Marina;PIVA, Francesco;GASPARRINI, SILVIA;DORIA, ANDREA;MONTIRONI, Rodolfo
2017-01-01
Abstract
Chemokines are a class of low-molecular-weight proteins that induce chemotaxis and are implicated in the modulation of angiogenesis. The imbalance among angiogenic and antiangiogenic chemokines can promote the development of several conditions, including chronic inflammation, dysplastic transformation and cancer. In this review, we describe the activity and clinical significance of chemokines in prostate and renal tumors and provide an update on ongoing studies in this setting.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
